Improving lives and livelihoods
Since 1843, when Rothamsted Research was founded, the National Institutes of Bioscience have contributed to major research successes including the discovery and development of key herbicides and insecticides; the creation of plant and livestock transgenics to improve crop yields and livestock breeding; the understanding of infectious diseases and the development of diagnostic tests and vaccines to control them. Further global challenges being tackled at the Institutes today include: ensuring food security and safety; tackling climate change and our dependence on fossil fuels; antimicrobial resistance and ageing to ensure lifelong health and wellbeing. The National Institutes of Bioscience’s collaborations with industry are accelerating the discovery and development of new therapeutics, biofuels, and food and drink products.
Researchers at John Innes Centre inserted new genes into a plant genome, using a soil bacterium. Plant transformation technology is born!
Researchers at John Innes Centre made the first hybrid antibiotic by combining the antibiotic gene clusters of different strains of Streptomyces bacteria.
Researchers at the John Innes Centre discover that the order of genes in cereal crops is remarkably similar, which has important implications for crop improvement.
Researchers at The Roslin Institute create Dolly the sheep, the first mammal to be cloned from an adult body cell using somatic cell nuclear transfer.
As part of an international consortium, scientists from IFR contributed to sequence the genome of baker’s yeast, Saccharomyces cerevisiae.
Researchers at IFR provide evidence for the first food-specific health claim by showing that oat beta glucan is heart-healthy.
The Pirbright Institute provided evidence linking bovine spongiform encephalopathy (BSE) in cattle and the human disease ‘new variant’ Creutzfeldt–Jakob disease (vCJD).
‘Green Revolution’ gene discovered. Scientists at the John Innes Centre create of Dwarfed wheat varieties that result in huge increases in yield
Novacta Biosystems is the first spin-out company from JIC. It focuses on developing treatments against drug-resistant bacteria.
Scientists at Babraham uncover mechanisms through which the environment affects gene activity (epigenetics) and their importance for health and disease.
Scientists at Rothamsted Research provided evidence that the waggle dance directs bees to food sources.
Researchers at IFR developed a computer-controlled model that predicts the digestion of real foods and medicines within the human gut.
The Roslin Institute pioneer the use of transgenic hens to produce low-cost protein drugs.
Scientists at the Pirbright Institute develop a rapid on-farm test for foot-and-mouth disease virus.
Scientists at the John Innes Centre produce GM purple tomatoes with raised levels of the anti-cancer compound: anthocyanin.
Scientists at Pirbright contributed to the Global Rinderpest Eradication Programme, which achieved its objective in 2010.
Scientists from TGAC kickstart a crowdsourcing effort which mobilised researchers to sequence and analyse DNA from the E. Coli strain at the source of a deadly epidemic.
Scientists at JIC launch the OpenAshDieBack project Fraxinus – an ‘open source’ platform for scientists to share their data and publish results more quickly.
Scientists from the Pirbright Institute contribute to the development of a synthetic vaccine for foot-and-mouth disease virus.